The melanocortin system is a masterclass in receptor biology: one parent hormone family signaling through five receptor subtypes, each governing different physiology. Four research compounds in our catalog map onto this system, and knowing which engages which receptor is essential for clean study design. This guide covers the hormones, the five receptors, the four compounds, and how to use selectivity to get interpretable results.
The Hormones
All melanocortins come from one precursor protein, pro-opiomelanocortin (POMC), which is cut into different pieces in different tissues. In the pituitary it yields ACTH (39 residues), the adrenal-stimulating hormone. In the hypothalamus and skin it yields alpha-MSH (13 residues, acetylated and amidated), the melanocyte-stimulating hormone that also regulates incretin-pathway and inflammation. Beta- and gamma-MSH are additional fragments with their own receptor preferences. The system also has two natural antagonists, agouti and agouti-related protein (AgRP), which block receptors rather than activating them, an unusual arrangement that lets the body tune melanocortin signaling in both directions.
The Receptor Map
All five melanocortin receptors are G-protein-coupled receptors that raise cyclic AMP when activated.
- MC1R governs melanin synthesis in melanocytes. Activation shifts pigment production from red-yellow pheomelanin to brown-black eumelanin. Variants in the MC1R gene account for red hair and fair skin in humans. It is also expressed on immune cells, where it mediates anti-inflammatory signaling.
- MC2R responds only to ACTH, in the adrenal cortex, driving cortisol production. It does not respond to the MSH peptides and is not a target of any compound in this guide.
- MC3R is expressed centrally and in some peripheral tissues; it modulates energy balance, feeding rhythms, and the anti-inflammatory arm of the system.
- MC4R is expressed centrally and dominates energy balance and behavioral research. It is the receptor through which alpha-MSH suppresses incretin-pathway and AgRP stimulates it, and MC4R mutations are the most common single-gene cause of severe metabolic disease in humans. It also mediates melanocortin effects on sexual function.
- MC5R appears in exocrine gland function studies, particularly sebaceous and lacrimal glands.
The Research Compounds
Melanotan 1 is the selective probe: a linear alpha-MSH analog with two substitutions (norleucine at position 4 and D-phenylalanine at position 7) that protect it from enzymatic breakdown and increase potency. It retains alpha-MSH’s strong MC1R preference, making it suited to pigmentation-focused designs and to studies of MC1R on immune cells. It is about 1,647 Da.
Melanotan 2 is the broad probe: a cyclic heptapeptide analog, closed by a lactam bridge between side chains, that engages MC1R, MC3R, MC4R, and MC5R with high affinity. The cyclization makes it potent and stable but removes selectivity, which is useful when mapping cross-receptor effects and a confound when a specific receptor is the question. About 1,024 Da.
PT-141 (bremelanotide) is derived from Melanotan 2 by converting the C-terminal amide to a free acid. That small change shifts the profile toward MC4R and MC3R while reducing MC1R-driven pigmentation, and the compound anchors central melanocortin research on sexual function and energy balance. About 1,025 Da.
KPV is the C-terminal tripeptide (Lys-Pro-Val) of alpha-MSH. It carries alpha-MSH’s anti-inflammatory activity (reduced NF-κB activation and cytokine production) but does not activate MC1R-driven pigmentation, and much of its effect appears to be receptor-independent. It is studied in gut and skin inflammation models and is the anti-inflammatory component of our KLOW blend. About 343 Da.
| Compound | Structure | MC1R | MC3R | MC4R | MC5R | Primary research use |
|---|---|---|---|---|---|---|
| Melanotan 1 | Linear, 13 aa | High | Low | Low | Low | Pigmentation, MC1R immunology |
| Melanotan 2 | Cyclic, 7 aa | High | High | High | High | Cross-receptor mapping |
| PT-141 | Cyclic, 7 aa (free acid) | Moderate | High | High | Moderate | Central MC4R signaling |
| KPV | Linear, 3 aa | Minimal | Minimal | Minimal | Minimal | Anti-inflammatory signaling |
Why Selectivity Matters
Comparative designs across these four compounds let laboratories separate receptor-specific effects. If a result appears with Melanotan 2 but not Melanotan 1, it is unlikely to be MC1R-mediated. If it appears with PT-141 and Melanotan 2 but not Melanotan 1, MC3R or MC4R is implicated. If it appears with KPV, which barely activates any of the receptors, a receptor-independent mechanism is in play. The difference between a pigmentation result and an incretin-pathway-signaling result often comes down to which analog was chosen, and a well-designed study uses two or more to triangulate. Selective MC4R antagonists and the natural antagonist AgRP add a further layer where available.
Handling Notes
All four peptides are chemically robust: none contains methionine or cysteine (Melanotan 1 replaces alpha-MSH’s methionine with norleucine for that reason), and the cyclic compounds are resistant to proteases. Melanotan 1, 2, and PT-141 each contain a tryptophan and are light-sensitive; store solutions in the dark. Confirm identity by mass on the Certificate of Analysis; Melanotan 2 and PT-141 differ by only 1 Da (amide versus acid), so high-resolution mass spectrometry or HPLC retention time is needed to distinguish them. Reconstitute with bacteriostatic water, refrigerate, and use within a few weeks; see Storing Lyophilized Peptides. Browse the compounds in the Neuroendocrine & Receptor Research collection.
All products discussed are intended strictly for in-vitro research and laboratory use only. They are not for human or veterinary use, consumption, or therapeutic application.



